Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 6

Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia

Total article views   HTML views PDF downloads Totals
12,632 Dovepress* 10,269+ 2,092 12,361
PubMed Central* 2,363 1,025 3,388
Totals 12,632 3,117 15,749
*Since 5 August 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar